Colorectal

Science

Long-term yogurt consumption tied to decreased incidence of certain types of colorectal cancer

Yogurt, which contains live strains of bacteria, is thought to protect against many types of diseases, with some reports indicating…

Read More »
Science

Combination of dual-targeted therapies and chemotherapy shows high response rates in BRAF-mutated metastatic colorectal cancer

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies encorafenib and…

Read More »
Business

Pfizer’s BRAFTOVI ® Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer

Clinically meaningful and statistically significant results from the Phase 3 BREAKWATER trial show objective response rate of 61% with Pfizer…

Read More »
Back to top button